| Also known as |
Anastrozol |
| Blood pressure |
Can sometimes lower blood pressure due to reduced estrogen levels |
| Chemical name |
2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropiononitrile) |
| Dosage (medical) |
Typically 1 mg per day |
| Dosage (sports) |
Not commonly prescribed for sports uses, but dosages in unofficial contexts can vary |
| Effects |
Reduces estrogen levels, useful in the treatment of estrogen receptor-positive breast cancer |
| Formula |
C17H19N5 |
| Half-life |
Approximately 50 hours |
| Hepatotoxicity |
Low potential for liver toxicity, but liver function tests are recommended during prolonged use |
| Lab Test |
Estrogen levels, liver function tests |
| Main action |
Inhibits the enzyme aromatase, which is responsible for converting androgens to estrogens |
| Side effects |
Hot flashes, joint symptoms, weakness, mood changes, bone loss, increased risk of osteoporosis |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Strength |
1 mg |
| Substance class |
Aromatase inhibitor |
| Trade name |
Arimidex |
| Use in sports |
Sometimes used by bodybuilders to reduce the effects of estrogen related to the use of anabolic steroids |
| Water Retention |
Reduces water retention secondary to decreased estrogen levels |
| Manufacturer |
Pharmaceutical |
